Researchers have discovered the first known Android malware to use generative AI in its execution flow, using Google's Gemini ...

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside these models. The new method could lead to more reliable, more efficient, ...

Chatbots can talk with you. But what if they could talk to one another?

See 10 good vs bad ChatGPT prompts for 2026, with examples showing how context, roles, constraints, and format produce useful answers.

What sets Codeflash apart, he argues, is that it operates not just as a one-time audit or consultancy (as many optimization firms do) but as a continuous engine: “Codeflash has beaten us at optimizing ...

No matter who wins the Super Bowl, New York Jets fans lose Parents have questions over adult joke in Disney's new "Muppets Show" What you need to know before filing your taxes When you have to pay ...

During the 2026 Spring Festival, Tencent’s Yuanbao rolled out a high-stakes “all-in” move that made the entire internet industry sit up and take notice: a 1-billion-yuan cash red-envelope giveaway, ...

In November 2025, Anthropic, the Amazon and Google-backed AI firm behind Claude, came out with a startling claim: a Chinese state-sponsored group was using its chatbot’s coding capabilities to execute ...

There's no cooler short-game shot than a low-spinning pitch that stops on a dime. What's the secret? You can learn it with a simple drill. Get into your regular pitch address position. Place your ...

Burmese pythons are an invasive species in South Florida, originally from Southeast Asia and introduced through the pet trade. The non-venomous constrictors disrupt the ecosystem by preying on native ...

The chair of a federal vaccine advisory panel under anti-vaccine Health Secretary Robert F. Kennedy Jr. made his stance clear on vaccines in a podcast last week—and that stance was so alarming that ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans to pull away from late-stage clinical trial investments in the area. “We ...